PAJARILLAGA, PAULA BIANCA B.

BSN 4B/B1
DRUG STUDY
NAME OF DRUG DOSAGE & ROUTE ACTION INDICATION SIDE EFFECT NURSING RESPONSIBILITIES
Generic Name: Dosage:  Unknown. May  Bipolar disorder for  CNS: ataxia, dizziness,  Before administering the medication
Lamotrigine Adults: Initially, 25 inhibit release of maintenance drowsiness, headache, check the rights of drug administration.
mg immediate-release glutamate and treatment to delay somnolence, fatigue, anxiety,  Check if the patient is not allergy to
Brand Name: P.O. once daily for 2 aspartate time to occurrence abnormal thinking, memory, the drug.
Lamictal weeks; then 50 mg (excitatory of mood episodes depression, confusion,  Starter and titration kits are available
P.O. once daily for 2 neurotransmitters) (depression, mania, dysarthria, emotional lability, to provide doses consistent with
Therapeutic Class: weeks. Dosage may in the brain via hypomania, mixed fever, incoordination, recommended titration schedule for
Anticonvulsants then be doubled at action at voltage- episodes) in patients insomnia, irritability, malaise, the first 5 weeks of treatment.
weekly intervals, to sensitive sodium treated for acute suicidal ideation.  Chewable dispersible tablets may be
Pharmacologic Class: maintenance dosage of channels. mood episodes with  CV: palpitations, chest pain, swallowed whole, chewed, or
Phenyltriazines 200 mg daily standard therapy. edema. dispersed in water or diluted fruit
 EENT: blurred vision, juice.
Route: diplopia, vision abnormality,  If tablets are chewed, give a small
By mouth rhinitis, nystagmus, amount of water or diluted fruit juice
pharyngitis. to aid in swallowing.
 GI: nausea, vomiting,  Use cautiously in patients with renal,
abdominal pain, anorexia, hepatic, or cardiac impairment.
constipation, diarrhea, dry  Observe and inform the patient about
mouth, dyspepsia. GU: the overdose S&S: Ataxia, nystagmus,
amenorrhea, dysmenorrhea, increased seizures, decreased level of
urinary frequency. consciousness, coma, intraventricular
 Musculoskeletal: arthralgia, conduction delay.
back pain, muscle spasm,  Closely monitor all patients taking or
neck pain, weakness. starting AEDs for changes in behavior
Respiratory: cough, dyspnea, indicating worsening of suicidal
bronchitis. thoughts or behavior or depression.
 Skin: rash, dermatitis Symptoms such as anxiety, agitation,
hostility, mania, and hypomania may
be precursors to emerging suicidality.
 Reduce lamotrigine dose if drug is
added to a multidrug regimen that
includes valproic acid.